Skip to main navigation Skip to search Skip to main content

Hemostasis in Liver Disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The coagulopathy of liver disease is often multifactorial, and symptoms may be minimal for the degree of coagulopathy until the liver disease is very severe. Decreases in production of coagulation factors and associated disturbances in biliary function cause abnormalities that lead to both prothrombotic and hemorrhagic diatheses. Platelet counts are decreased due to decreased thrombopoiesis from the lack of thrombopoietin as well as increased destruction from hypersplenism. The pathologies that cause the hepatopathy often have an effect on hemostasis: alcohol, warfarin, autoimmune disorders, and hepatitis all have direct coagulopathic consequences. In this chapter, we hope to help the reader understand the intricate balance between clotting and bleeding in liver disease and to interpret the results of both routine and specialized coagulation testing in the assessment of the patient with liver disease that will result in optimal management for these complex patients.

Original languageEnglish (US)
Title of host publicationTransfusion Medicine and Hemostasis
Subtitle of host publicationClinical and Laboratory Aspects
PublisherElsevier
Pages605-608
Number of pages4
ISBN (Electronic)9780323960144
ISBN (Print)9780323960151
DOIs
StatePublished - Jan 1 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anticoagulation
  • Cirrhosis
  • Coagulopathies
  • DIC
  • Liver disease
  • Thrombopoietin receptor agonists
  • Vitamin K

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Hemostasis in Liver Disease'. Together they form a unique fingerprint.

Cite this